drugset / Trial / NCT07383415

Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia

NCT07383415

Not yet recruiting 20 enrolled Amin Javer
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates whether adding topical insulin to intranasal platelet-rich plasma (PRP) improves smell recovery in adults with post-inflammatory anosmia. Participants will be randomly assigned to receive either intranasal PRP combined with topical insulin or intranasal PRP alone. Changes in olfactory function will be assessed over time to compare the effectiveness and safety of the two treatments.

Timeline

Start
2026-03-30
Primary completion
2026-12-30
Completion
2027-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Topical
Comparator Platelet Rich Plasma Other / unclassified Intranasal

Indications